2021 promises to be a year of continued innovation and change in the biopharmaceutical industry. While the biopharmaceutical sector has traditionally been labelled as highly resistant to recessions, COVID-19 has presented and will continue to present some daunting challenges, ranging from fast-paced digitalization to disruptions in supply chains and clinical trials.
As the COVID-19 pandemic continues to take its toll on businesses worldwide, pharmaceutical companies will be looking for new ways to create value, prepare for the future, and remain competitive in the ever-changing business landscape.
In this webinar Bonnie Bain, Global Head of Healthcare Operations and Strategy, Kitty Whitney, Director of Thematic Analysis, and Urte Jakimaviciute, Senior Director of Market Research, will indicate the top trends that are going to shape pharmaceutical industry in 2021. The webinar will cover the most impactful emerging technologies, industry, regulatory, and microeconomic factors that are going to impact industry’s performance and growth prospects.
The webinar will include insights from pharmaceutical industry respondents that were surveyed for GlobalData’s “The State of the Biopharmaceutical Industry – 2021” report, followed by a Q&A session.
Key Learning Objectives
- Assess the impact of the COVID-19 pandemic on the biopharmaceutical sector
- Identify industry themes that will have the greatest positive or negative impact in 2021
- Learn which emerging technologies are expected to transform pharmaceutical sector
- Determine how quickly pharmaceutical sector can recover from COVID-19 impact
